Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
about
Review: Hypertension, a health economics perspectiveEconomic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.Promoting the health of senior citizensCardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs.The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.Health economics of heart failure.Reducing the growing burden of cardiovascular disease in the developing worldCosts and effectiveness of cardiac rehabilitation for dialysis patients following coronary bypassCost-effectiveness evaluation of a collaborative patient education hypertension intervention in Utah.Cost-effective strategies for the management of vascular disease.An Expert System for Enhancing Compliance with American Heart Association Guidelines for Reduction of Risk of Coronary Artery Disease.A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain.
P2860
Q22299226-8CE93A5F-988C-4F68-9C18-B5FAC35295B6Q33631450-9AC0C1AE-66B0-41BA-A174-A23B62661A6AQ34025979-B116B932-7F3B-47CB-8D2A-8A7029121485Q35201110-F8E99F7D-51D0-4DAA-94BE-C2E30FA1FCF2Q35538980-D9C3BAC3-53A1-4B2F-BFB7-1881D0219EF8Q35578931-BCE2CD86-4923-46F2-A46E-A925AB477E06Q36628358-3EAD7498-D18F-4CC9-8525-821200953A16Q37421762-FFB8ACB3-B0B7-44C6-97C9-388EDB56EECCQ39525525-6CE22423-A529-42A7-BACF-91095F3E793EQ41740403-1C043B84-E1A8-4292-B751-C1F17C0E701AQ45772254-88B73099-5E0C-41AA-BF8E-5249BF8D27B0Q51204046-D034BD5C-A813-4B2E-8531-29A717BEB74E
P2860
Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
@en
type
label
Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
@en
prefLabel
Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
@en
P2093
P1476
Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.
@en
P2093
Holmes-Rovner M
Kupersmith J
P304
P356
10.1016/S0033-0620(05)80009-X
P577
1995-01-01T00:00:00Z